LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 2,184.00p on 16-02-2026 at 19:30:06 |
|---|---|
| Change | 19.00p 0.88% |
| Buy | 2,182.00p |
| Sell | 2,180.00p |
| Last Trade: | Sell 13,022.00 at 2,181.329p |
| Day's Volume: | 8,105,053 |
| Last Close: | 2,184.00p |
| Open: | 2,172.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,153.00p - 2,187.00p |
| 52wk Range: | 1,242.50p - 2,219.00p |
| Market Capitalisation: | £87.65b |
| VWAP: | 2,175.23072p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 13,022 | 2,181.329p | SI Trade Suspected SELL Trade |
16:47:10 - 16-Feb-26 |
| Buy* | 1,227,949 | 2,184.00p | Suspected BUY Trade |
16:35:26 - 16-Feb-26 |
| Sell* | 68 | 2,181.00p | Automatic Execution |
16:29:50 - 16-Feb-26 |
| Sell* | 80 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Buy* | 900 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Buy* | 930 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Buy* | 1,517 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Buy* | 465 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Sell* | 3,080 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
| Sell* | 2,506 | 2,181.00p | Automatic Execution |
16:29:44 - 16-Feb-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 11th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 10th Feb 2026 7:00 am | RNS | China CDE accepts Arexvy adults 60+ application |
| 9th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 6th Feb 2026 10:30 am | RNS | Director/PDMR Shareholding |